Finally, Gal-1 expression correlates with adverse outcome in ALK- ALCL patients, which show less cytotoxic T cells in their microenvironment compared to Gal-1 depleted cases [342]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.